Datasetdouble_gel_and_single_gel_rma_expression_values_collapsed_to_symbols.class.cls
#double_gel_8d_versus_double_gel_72h.class.cls
#double_gel_8d_versus_double_gel_72h_repos
Phenotypeclass.cls#double_gel_8d_versus_double_gel_72h_repos
Upregulated in classdouble_gel_8d
GeneSetTSA_HEPATOMA_CANCER_UP
Enrichment Score (ES)0.7168472
Normalized Enrichment Score (NES)2.050946
Nominal p-value0.0
FDR q-value0.0033908063
FWER p-Value0.09
Table: GSEA Results Summary



Fig 1: Enrichment plot: TSA_HEPATOMA_CANCER_UP   
Profile of the Running ES Score & Positions of GeneSet Members on the Rank Ordered List

PROBEGENE SYMBOLGENE_TITLERANK IN GENE LISTRANK METRIC SCORERUNNING ESCORE ENRICHMENT
1COL1A2COL1A2
Entrez,  Source
collagen, type I, alpha 231.0460.2667Yes
2CTGFCTGF
Entrez,  Source
connective tissue growth factor320.6600.4330Yes
3TIMP2TIMP2
Entrez,  Source
TIMP metallopeptidase inhibitor 2350.6420.5966Yes
4CD9CD9
Entrez,  Source
CD9 molecule2990.2500.6408Yes
5VEGFCVEGFC
Entrez,  Source
vascular endothelial growth factor C4960.1830.6727Yes
6HBEGFHBEGF
Entrez,  Source
heparin-binding EGF-like growth factor7170.1490.6942Yes
7JUNBJUNB
Entrez,  Source
jun B proto-oncogene8660.1320.7168Yes
8BADBAD
Entrez,  Source
BCL2-antagonist of cell death17500.0830.6716No
9TGFB1TGFB1
Entrez,  Source
transforming growth factor, beta 1 (Camurati-Engelmann disease)20790.0710.6650No
10CAV2CAV2
Entrez,  Source
caveolin 221510.0690.6771No
11ANK1ANK1
Entrez,  Source
ankyrin 1, erythrocytic26570.0560.6535No
12RHOGRHOG
Entrez,  Source
ras homolog gene family, member G (rho G)28190.0520.6547No
13NGFRNGFR
Entrez,  Source
nerve growth factor receptor (TNFR superfamily, member 16)28680.0510.6643No
14PDGFRBPDGFRB
Entrez,  Source
platelet-derived growth factor receptor, beta polypeptide28710.0510.6772No
15BSGBSG
Entrez,  Source
basigin (Ok blood group)39280.0310.6059No
16LUMLUM
Entrez,  Source
lumican47280.0190.5508No
17ARHGDIBARHGDIB
Entrez,  Source
Rho GDP dissociation inhibitor (GDI) beta50750.0140.5285No
18VTNVTN
Entrez,  Source
vitronectin51290.0140.5280No
19QSCN6QSCN6
Entrez,  Source
quiescin Q653850.0100.5114No
20CDKN2CCDKN2C
Entrez,  Source
cyclin-dependent kinase inhibitor 2C (p18, inhibits CDK4)6239-0.0010.4476No
21CASP9CASP9
Entrez,  Source
caspase 9, apoptosis-related cysteine peptidase6766-0.0080.4101No
22MMP11MMP11
Entrez,  Source
matrix metallopeptidase 11 (stromelysin 3)6969-0.0100.3976No
23FASTKFASTK
Entrez,  Source
Fas-activated serine/threonine kinase7022-0.0110.3964No
24CD8BCD8B
Entrez,  Source
CD8b molecule8424-0.0300.2988No
25PLA2G6PLA2G6
Entrez,  Source
phospholipase A2, group VI (cytosolic, calcium-independent)8737-0.0340.2841No
26ITGA7ITGA7
Entrez,  Source
integrin, alpha 79373-0.0430.2473No
27JUPJUP
Entrez,  Source
junction plakoglobin10241-0.0570.1968No
28FBN2FBN2
Entrez,  Source
fibrillin 2 (congenital contractural arachnodactyly)10607-0.0640.1859No
29IGFBP2IGFBP2
Entrez,  Source
insulin-like growth factor binding protein 2, 36kDa11121-0.0760.1668No
Table: GSEA details [plain text format]



Fig 2: TSA_HEPATOMA_CANCER_UP   
Blue-Pink O' Gram in the Space of the Analyzed GeneSet



Fig 3: TSA_HEPATOMA_CANCER_UP: Random ES distribution   
Gene set null distribution of ES for TSA_HEPATOMA_CANCER_UP